Numerous studies have shown that the proinflammatory cytokine IL-17 directly or indirectly promotes tumour angiogenesis and cell proliferation and that it inhibits apoptosis via the activation of inflammatory signalling pathways; IL-17 therefore contributes to the progression of lung cancer. The gene discussed is IL17A; the disease is lung carcinoma.